Frequency Therapeutics Inc (KRRO) stock has hit a 52-week low, trading at $29.8, marking a significant downturn for the company within the past year. According to InvestingPro data, the company ...

Cognito Therapeutics today announced the appointment of four new executives to accelerate its growth and commercialization ...

This study found that oxytocin had particularly strong effects in women, promoting lower blood pressure and reducing norepinephrine, a hormone associated with the body’s stress response. Additionally, ...

This important study demonstrates the potential of synthetic gene circuits to detect and target aberrant RAS activity in cancer cell lines. The circuit design is novel and the evidence supporting the ...